Tuesday 17 March 2026

One To Watch

BIND Therapeutics


Want to Update your Company's Profile?


Latest BIND Therapeutics News

BIND Therapeutics says Pfizer's $40 million bid for its assets is the winner
27 July 2016
BIND Therapeutics accepts 'stalking horse' bid from Pfizer
2 July 2016
BIND Therapeutics collaborates with Affilogic
7 May 2016
PeptiDream inks research deal with BIND Therapeutics
7 April 2016
More BIND Therapeutics news >


Today's issue

By George Medicines, another GMRx2 deal
Pharmaceutical
By George Medicines, another GMRx2 deal
16 March 2026
Pharmaceutical
Deal gives Sentynl shot at second HGPS treatment
16 March 2026
Generics
Middle East conflict threatens India’s pharma exports, losses could top $541 million
16 March 2026
Biotechnology
Continued positive trial results for CytomX’s varsetatug masetecan
16 March 2026
Pharmaceutical
Sovereign wealth funds: the new life science kingmakers?
16 March 2026
Biotechnology
Almirall Phase III pediatric eczema results ‘meaningful’
16 March 2026
Pharmaceutical
New Kerendia top-line data for adults with non-diabetic CKD
16 March 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze